Viramal

London, United Kingdom Founded: 2013 • Age: 13 yrs
Viramal is focused on developing transformative medicines for women.
Annual revenue - Latest available
Total funding - 1 rounds
Employees 13 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors 11 Brand Intelligence

About Viramal

Viramal is a company based in London (United Kingdom) founded in 2013. It operates as a HealthTech. The company has 13 employees as of April 30, 2022. Viramal offers products and services including Transdermal Therapies and Vaginal Well-being Products. Viramal operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter London, United Kingdom
  • Employees 13 as on 30 Apr, 2022
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Viramal Limited
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    13

    as on Apr 30, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Viramal

Viramal offers a comprehensive portfolio of products and services, including Transdermal Therapies and Vaginal Well-being Products.

Product name locked
Category locked
Primary

Innovative transdermal treatments for women's health conditions.

Product name locked
Category locked
Locked

Products focused on maintaining vaginal health effectively.

People of Viramal

Headcount
Employee Profiles 3
Employee Profiles
People
Oliver Bates
Chief Executive Officer and Co-Founder

Unlock access to complete

Funding Insights of Viramal

Investments & Acquisitions by Viramal

Investments
Premium access

Investment portfolio details for Viramal

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Viramal

Premium access

Detailed financials for Viramal

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Viramal Comparisons

Viramal Primary company
Description
Viramal is focused on developing transformative medicines fo...
Location
London, United Kingdom
Founded Year
2013
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
13
As of 2022
Premium access

Peer comparison for Viramal

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Viramal

Viramal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of pharmaceuticals and vaccines for various therapeutic areas
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Yeast cells are genetically engineered to produce medicinal products.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
CRISPR-engineered cell and gene therapies are developed for research applications.
Premium access

Detailed competitors of Viramal

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Viramal

Premium access

Complete news archive for Viramal

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viramal

Viramal was founded in 2013 and raised its 1st funding round 5 years after it was founded.

Viramal is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

As of Apr 30, 2022, the latest employee count at Viramal is 13.

Viramal, a specialist pharmaceutical company, is engaged in creating innovative biological and vaginal well-being products for women. Based in the UK and Sweden, the company is dedicated to addressing neglected areas of womens sexual and reproductive health. Solutions are developed for conditions such as endometriosis, menopause, and chronic pelvic pain through proprietary transdermal and trans-vaginal technologies. A safer medical approach is prioritized to minimize side effects while maximizing efficacy. The portfolio includes both prescription and non-prescription treatments aimed at improving womens quality of life across various life stages.

Viramal's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Viramal offers Transdermal Therapies and Vaginal Well-being Products.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available